Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder. Normally, air should flow smoothly from the mouth and nose into the lungs at all times, including during sleep.

Sleep apnea affects over 29 million Americans, with Obstructive Sleep Apnea (characterized by pauses in breathing during ...

Tirzepatide, a GLP-1 medication already on the market to treat diabetes, is now FDA approved to help those suffering from ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

China: A recent study published in the Journal of the American Heart Association has unveiled a compelling association ...

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...

For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for motor vehicle accidents (MVA) compared with continuous positive airway pressure (CPAP ...

A new study published in the journal of Sleep and Breathing found that people with obstructive sleep apnea (OSA) were 43% ...

Healthcare announced the appointment of Alison Wimms, Ph.D. as an advisor to its newly formed IHL-42X Obstructive Sleep Apnea ...

Signifier Medical secures EU MDR certification for eXciteOSA®, ensuring safety, efficacy, and broader access to its ...

Obstructive Sleep Apnea (OSA) is a common sleep disorder in children characterized by repeated interruptions in breathing during sleep due to the obstruction of the upper airway. This condition ...